Finance
Vista Medical announces completion of private placement
Published in Obesity and Diabetes Week, June 21st, 2004
The investment round was led by MedCap Management and Research LLC. Dawson James Securities through ViewTrade Financial acted as exclusive financial advisor to, and as sole placement agent for, Vista Medical.
The company sold 5,454,544 units of its securities for $0.85 per unit, each unit consisting of one share of common stock and one warrant to purchase one-half share of common stock, for aggregate gross proceeds of approximately $4.6 million or $4.1 million net of expenses.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Therapy
Diabetes in older adults reviewed - Diabetes Therapy
Language used in relation to diabetes may undermine therapy efforts - Diet and Nutrition
Arabinogalactan offers no long-term benefits on serum lipids or glucose - Endocrinology
Metabolic products measured by NMR analysis of one glucose derivative - Obesity Pathogenesis
Gastrointestinal satiety signals reviewed - Atherosclerosis
PAD patients should be aggressively treated for atherosclerotic risk factors - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
